MARKET WIRE NEWS

Overweight Recommendation Issued On BBIO By Barclays

Source: KlickAnalytics

2026-03-10 17:15:05 ET

  • Barclays analyst issues OVERWEIGHT recommendation for BBIO on March 10, 2026 04:42PM ET.
  • The previous analyst recommendation was Overweight.
  • BBIO was trading at $74.32 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 25 - Buy, 1 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    Full story available on KlickAnalytics.com
    BridgeBio Pharma Inc.

    NASDAQ: BBIO

    BBIO Trading

    -4.84% G/L:

    $68.97 Last:

    696,555 Volume:

    $70.35 Open:

    mwn-link-x Ad 300

    BBIO Latest News

    BBIO Stock Data

    $13,905,867,946
    157,635,809
    2.34%
    155
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    Palo Alto

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App